← All diseases Heart and blood vessels

Cardiac amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (41)Meta-analysis (6)Treatment guideline (1)Phase 3 study (19)Systematic review (12)Randomized Controlled Trial (3)Clinical trial (374)Review article (178)Early study (phase 1 or 2) (7)Description of some patients (200)Laboratory or animal study (2)Commentary or Editorial (87) Studies currently recruiting participants only (39)

Filter

Publications and studies (1423)

• A histopathologic schema to quantify the burden of cardiac amyloidosis: Relationship with survival and echocardiographic parameters. (2019/02/01) ♡
• Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. (2019/01/17) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis. (2019/01/01) ♡
• Intramuscular interstitial amyloid deposition does not impact anoctaminopathy-5 phenotype. (2019/01/01) ♡
• Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autonomic dysfunction: Diagnosis and management. (2019/01/01) ♡
• LEFT ATRIAL FUNCTION AND VOLUME BY MAGNETIC RESONANCE IN PATIENTS WITH HEREDITARY AMYLOIDOSIS. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of MyoStrain™ in Clinical Practice (2019-11-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Diagnosis of Cardiac Amyloidosis With 99mTc-PYP; Comparison Between Planar Imaging, SPECT/CT and Cardiac-dedicated CZT Camera (2019-11-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Potential Role of 18F-NaF PET/CT in Diagnosing Cardiac Amyloidosis (2019-10-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II (2019-10-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698 (2019-10-16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging (2019-08-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy (2019-08-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ATTR Expanded Access Program (EAP) by Ionis (2019-08-05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I (2019-07-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD (2019-07-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PET/MRI Evaluation of Cardiac Amyloid (2019-07-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR) (2019-06-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of Amyloidosis on TAVI Patients (2019-06-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (2019-04-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis (2019-04-05) ♡
• Mispacking of the Phe87 Side Chain Reduces the Kinetic Stability of Human Transthyretin. (2018/12/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lingual liability: macroglossia and dyspnoea as the harbinger of systemic AL (light-chain) cardiac amyloidosis. (2018/12/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis. (2018/12/20) ♡
• Evaluation of strain indexes and prognosis of patients with cardiac amyloidosis with preserved LVEF by three-dimensional speckle tracking imaging. (2018/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy. (2018/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. (2018/12/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Incidentally Detected Amyloid Light-Chain Amyloidosis Caused by Monoclonal Gammopathy of Undetermined Significance: Possible Time-Dependent Change in Colonic Findings. (2018/12/06) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. (2018/12/04) ♡
• High-efficient bacterial production of human ApoA-I amyloidogenic variants. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloid Registry Kiel: An interim balance. (2018/12/01) ♡
• Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016. (2018/12/01) ♡
• Borderline left ventricular ejection fraction is associated with alterations in mitral annular size and function. Results from the three-dimensional speckle-tracking echocardiographic MAGYAR-Healthy Study. (2018/12/01) ♡
• Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset. (2018/12/01) ♡
• Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy. (2018/12/01) ♡
• Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis. (2018/12/01) ♡
• A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement. (2018/12/01) ♡
• Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis. (2018/12/01) ♡
• Correction: Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. (2018/11/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapies for cardiac light chain amyloidosis: An update. (2018/11/15) ♡
• Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis. (2018/11/09) ♡
• Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis. (2018/11/06) ♡
• Deferred autologous stem cell transplantation in systemic AL amyloidosis. (2018/11/05) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Role of (99m) Tc-DPD scintigraphy in imaging extra-cardiac light chain (AL) amyloidosis. (2018/11/01) ♡
• Investigating the preventive effects of baicalin and gallocatechin against glyoxal-induced cystatin aggregation. (2018/11/01) ♡
• Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis. (2018/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Systemic immunoglobulin light chain amyloidosis. (2018/10/25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. (2018/10/23) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.